Projects per year
Personal profile
Research Area Keywords
- Cancer
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Butler, E. B., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Zhang, J., Chan, E. Y., Gibbs, J. M., Heyne, K., Kim, M. P., Singh, M. & Sultenfuss, M. A.
9/16/21 → …
Project: Clinical Trial
-
1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Wiechmann, C., Gee, K., Burns, E. A., Xu, J., Zhang, Y., Crenshaw, A., Esmail, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Efstathiou, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1360-A1360Research output: Contribution to journal › Article › peer-review
-
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
Gee, K., Wiechmann, C., Burns, E. A., Xu, J., Zhang, Y., Esmail, A., Crenshaw, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1361-A1361Research output: Contribution to journal › Article › peer-review
-
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
Guan, J., Sun, K., Guerrero, C. A., Zheng, J., Xu, Y., Mathur, S., Teh, B. S., Farach, A., Zhang, J., Butler, E., Pan, P. Y., Zsigmond, E., Mei, Z., Mejia, J., Chen, S. H., Chang, J. C. & Bernicker, E. H., Aug 24 2023, (E-pub ahead of print) In: International Journal of Radiation Oncology Biology Physics.Research output: Contribution to journal › Article › peer-review
-
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy
Riveros, C., Ranganathan, S., Xu, J., Chang, C., Kaushik, D., Morgan, M., Miles, B. J., Muhammad, T., Anis, M., Aghazadeh, M., Zhang, J., Efstathiou, E., Klaassen, Z., Brooks, M. A., Rini, B., Wallis, C. J. D. & Satkunasivam, R., Mar 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 3, p. 150.e1-150.e9Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, K. T., Chevli, N. C., Messer, J. A., Haque, W., Farach, A. M., Satkunasivam, R., Zhang, J., Darcourt, J., Lo, S. S., Siva, S., Butler, E. B. & Teh, B. S., Mar 2023, In: Clinical and Translational Radiation Oncology. 39, p. 100592 100592.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations